Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomewide Meta‐Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent‐Induced Sensory Peripheral Neuropathy
Katherina C. Chua, Chenling Xiong, Carol Ho, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 108, Iss. 3, pp. 625-634
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Genomewide Association Studies in Pharmacogenomics
Gregory McInnes, Sook Wah Yee, Yash Pershad, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 110, Iss. 3, pp. 637-648
Open Access | Times Cited: 71
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
Daniel L. Hertz, Markus Joerger, Yung‐Jue Bang, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114024-114024
Open Access | Times Cited: 11
Current opinion on the pharmacogenomics of paclitaxel-induced toxicity
Zeina N. Al‐Mahayri, Mohammad M. AlAhmad, Bassam R. Ali
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 7, pp. 785-801
Closed Access | Times Cited: 51
Targeting the Sphingosine-1-Phosphate Axis for Developing Non-narcotic Pain Therapeutics
Silvia Squillace, Sarah Spiegel, Daniela Salvemini
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 11, pp. 851-867
Open Access | Times Cited: 41
Chemotherapy and peripheral neuropathy
Tiffany Li, David Mizrahi, David Goldstein, et al.
Neurological Sciences (2021) Vol. 42, Iss. 10, pp. 4109-4121
Closed Access | Times Cited: 36
Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis
Ying Lin, Wei Yu, Yinghui Wei, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109910-109910
Closed Access | Times Cited: 14
A systematic review of genome-wide association studies for pain, nociception, neuropathy, and pain treatment responses
Song Li, Annika Brimmers, Regina L. M. van Boekel, et al.
Pain (2023) Vol. 164, Iss. 9, pp. 1891-1911
Open Access | Times Cited: 14
Review of the Contribution of Clinical and Genetic Factors to the Racial Disparity in Taxane-Induced Peripheral Neuropathy
Nam Nguyen-Hoang, Mustafa Nazzal, Bryan P. Schneider, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104739-104739
Closed Access
Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy
Zia Khan, Min Jung, Megan Crow, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons
Christina Mortensen, Mikkel Thy Thomsen, Katherina C. Chua, et al.
Neuropharmacology (2024) Vol. 258, pp. 110062-110062
Open Access | Times Cited: 3
Evolution of predictive risk factor analysis for chemotherapy-related toxicity
Daniel L. Hertz, Maryam B. Lustberg, Stephen T. Sonis
Supportive Care in Cancer (2023) Vol. 31, Iss. 10
Closed Access | Times Cited: 8
Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms
Andreas A. Argyriou, Jordi Bruna, Susanna B. Park, et al.
Expert Review of Neurotherapeutics (2020) Vol. 20, Iss. 10, pp. 1005-1016
Closed Access | Times Cited: 21
Mechanistic insights into the pathogenesis of microtubule‐targeting agent‐induced peripheral neuropathy from pharmacogenetic and functional studies
Katherina C. Chua, Nura El‐Haj, Josefina Priotti, et al.
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 130, Iss. S1, pp. 60-74
Open Access | Times Cited: 19
Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships
Daniel L. Hertz
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 2, pp. 227-239
Open Access | Times Cited: 17
Chemotherapy-induced peripheral neuropathy models constructed from human induced pluripotent stem cells and directly converted cells: a systematic review
Pascal S.H. Smulders, Kim Heikamp, Jeroen Hermanides, et al.
Pain (2024) Vol. 165, Iss. 9, pp. 1914-1925
Closed Access | Times Cited: 2
Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study
Kosar Hooshmand, David Goldstein, Hannah C. Timmins, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Machine learning and biological validation identify sphingolipids as key mediators of paclitaxel-induced neuropathy in cancer patients
Jörn Lötsch, Khayal Gasimli, Sebastian Malkusch, et al.
(2024)
Open Access | Times Cited: 1
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients
Jörn Lötsch, Khayal Gasimli, Sebastian Malkusch, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients
Jörn Lötsch, Khayal Gasimli, Sebastian Malkusch, et al.
eLife (2024) Vol. 13
Open Access | Times Cited: 1
A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
Anukriti Sharma, Ken B. Johnson, Bihua Bie, et al.
Technology in Cancer Research & Treatment (2022) Vol. 21, pp. 153303382211271-153303382211271
Open Access | Times Cited: 6
Inhibition of muscarinic receptor signaling protects human enteric inhibitory neurons against platin chemotherapy toxicity
Mikayla N Richter, Sina Farahvashi, Ryan M. Samuel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Predisposing Factors for the Development of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Daniel L. Hertz, Cindy Tofthagen, Sara Faithfull
Springer eBooks (2021), pp. 19-51
Closed Access | Times Cited: 7
Neuromuscular complications of cancer therapy
Andreas A. Argyriou, Jordi Bruna, Elisa Mantovani, et al.
Current Opinion in Neurology (2021) Vol. 34, Iss. 5, pp. 658-668
Closed Access | Times Cited: 6
Stem Cell‐Based Models for Studying the Effects of Cancer and Cancer Therapies on the Peripheral Nervous System
Mikayla N Richter, Faranak Fattahi
Advanced Biology (2022) Vol. 6, Iss. 9
Open Access | Times Cited: 3
Genome-Wise Analysis for Drug Targeting
Juveriya Israr, Shabroz Alam, Sahabjada Siddiqui, et al.
(2024), pp. 119-140
Closed Access
Page 1 - Next Page

Scroll to top